430 related articles for article (PubMed ID: 28290526)
41. B7‑H1‑mediated immunosuppressive properties in human mesenchymal stem cells are mediated by STAT‑1 and not PI3K/Akt signaling.
Jang IK; Jung HJ; Noh OK; Lee DH; Lee KC; Park JE
Mol Med Rep; 2018 Aug; 18(2):1842-1848. PubMed ID: 29901104
[TBL] [Abstract][Full Text] [Related]
42. Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism.
Yan Z; Zhuansun Y; Chen R; Li J; Ran P
Exp Cell Res; 2014 May; 324(1):65-74. PubMed ID: 24681107
[TBL] [Abstract][Full Text] [Related]
43. Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.
Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
Stem Cell Rev Rep; 2015 Jun; 11(3):442-52. PubMed ID: 25326368
[TBL] [Abstract][Full Text] [Related]
44. Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.
Li H; Wang W; Wang G; Hou Y; Xu F; Liu R; Wang F; Xue J; Hu T; Luan X
Cytotherapy; 2015 Nov; 17(11):1560-71. PubMed ID: 26432559
[TBL] [Abstract][Full Text] [Related]
45. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells.
Cahill EF; Tobin LM; Carty F; Mahon BP; English K
Stem Cell Res Ther; 2015 Mar; 6(1):19. PubMed ID: 25890330
[TBL] [Abstract][Full Text] [Related]
46. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions.
Bassani B; Tripodo C; Portararo P; Gulino A; Botti L; Chiodoni C; Jachetti E; Bolli N; Ciciarello M; Joehrens K; Anagnostopoulos I; Na IK; Curti A; Colombo MP; Sangaletti S
Front Immunol; 2021; 12():662048. PubMed ID: 34084166
[TBL] [Abstract][Full Text] [Related]
47. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
48. Bone marrow-derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion-induced lung injury.
Li J; Zhou J; Zhang D; Song Y; She J; Bai C
J Cell Mol Med; 2015 Oct; 19(10):2341-51. PubMed ID: 26177266
[TBL] [Abstract][Full Text] [Related]
49. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
50. TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival
Murphy N; Treacy O; Lynch K; Morcos M; Lohan P; Howard L; Fahy G; Griffin MD; Ryan AE; Ritter T
FASEB J; 2019 Aug; 33(8):9404-9421. PubMed ID: 31108041
[TBL] [Abstract][Full Text] [Related]
51. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
[TBL] [Abstract][Full Text] [Related]
53. IL-17 down-regulates the immunosuppressive capacity of olfactory ecto-mesenchymal stem cells in murine collagen-induced arthritis.
Tian J; Rui K; Tang X; Wang W; Ma J; Tian X; Wang Y; Xu H; Lu L; Wang S
Oncotarget; 2016 Jul; 7(28):42953-42962. PubMed ID: 27356747
[TBL] [Abstract][Full Text] [Related]
54. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
[TBL] [Abstract][Full Text] [Related]
55. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
56. Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand.
Nazzal D; Gradolatto A; Truffault F; Bismuth J; Berrih-Aknin S
Cell Death Dis; 2014 Sep; 5(9):e1420. PubMed ID: 25210803
[TBL] [Abstract][Full Text] [Related]
57. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
58. Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells.
Lin CL; Hsiao G; Wang CC; Lee YL
Pharmacol Res; 2016 Aug; 110():111-121. PubMed ID: 27185659
[TBL] [Abstract][Full Text] [Related]
59. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
[TBL] [Abstract][Full Text] [Related]
60. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
Hamel KM; Cao Y; Olalekan SA; Finnegan A
Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
